Cargando…
Cell Therapy for Refractory Angina: A Reappraisal
Cardiac cell-based therapy has emerged as a novel therapeutic option for patients dealing with untreatable refractory angina (RA). However, after more than a decade of controlled studies, no definitive consensus has been reached regarding clinical efficacy. Although positive results in terms of surr...
Autores principales: | Bassetti, Beatrice, Nigro, Patrizia, Catto, Valentina, Cavallotti, Laura, Righetti, Stefano, Achilli, Felice, Scacciatella, Paolo, Carbucicchio, Corrado, Pompilio, Giulio |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5742462/ https://www.ncbi.nlm.nih.gov/pubmed/29375624 http://dx.doi.org/10.1155/2017/5648690 |
Ejemplares similares
-
Linking cell function with perfusion: insights from the transcatheter delivery of bone marrow-derived CD133(+) cells in ischemic refractory cardiomyopathy trial (RECARDIO)
por: Bassetti, Beatrice, et al.
Publicado: (2018) -
Son of a Lesser God: The Case of Cell Therapy for Refractory Angina
por: Bassetti, Beatrice, et al.
Publicado: (2021) -
Diagnostic Potential of Plasmatic MicroRNA Signatures in Stable and Unstable Angina
por: D'Alessandra, Yuri, et al.
Publicado: (2013) -
Full GMP-Compliant Validation of Bone Marrow-Derived Human CD133(+) Cells as Advanced Therapy Medicinal Product for Refractory Ischemic Cardiomyopathy
por: Belotti, Daniela, et al.
Publicado: (2015) -
Young at Heart: Pioneering Approaches to Model Nonischaemic Cardiomyopathy with Induced Pluripotent Stem Cells
por: Gowran, Aoife, et al.
Publicado: (2016)